$2.70
-0.0100-0.37%
At Close: -
$2.69
-0.01-0.37%
After Hours: Sep 19, 4:00 PM EDT
15 minutes delayed
Evogene reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Evogene using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-22 | $-1.06 | $-1.20 | 11.7 % |
Mar 2024 | 2024-05-23 | $-0.80 | $-0.90 | 11.1 % |
Dec 2023 | 2024-03-07 | $-1.30 | $-1.40 | 7.14 % |
Sep 2023 | 2023-11-15 | $-0.80 | $-1.60 | 50.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-22 | $914.00K | $800.00K | 14.2 % |
Mar 2024 | 2024-05-23 | $4.19M | $3.50M | 19.7 % |
Dec 2023 | 2024-03-07 | $578.00K | $910.00K | -36.5 % |
Sep 2023 | 2023-11-15 | $3.77M | $1.18M | 219.2 % |
Evogene (EVGN) is scheduled to report earnings on November 13, 2024. The last reported earnings were for reported on August 22, 2024 for Q2.
The Actual EPS was $-1.06, which beat the estimate of $-1.20.
The Actual Revenue was $914K, which beat the estimate of $800K.
Browse earnings estimates, EPS, and revenue on all stocks.